We’re thrilled to be featured in TechCrunch, spotlighting NeuroBionics’ mission to transform neuromodulation therapy! Our bioelectric fibers, as thin as a human hair, offer a minimally invasive alternative to traditional deep brain stimulation, potentially transforming the treatment of neurological conditions like depression, epilepsy, and Parkinson’s.
Built on over a decade of MIT research, our technology uses carbon nanotubes for longer-lasting, safer, and MRI-compatible electrodes.
With an oversubscribed Seed Round of $5M funding led by Dolby Family Ventures, we’re advancing toward clinical trials to bring this breakthrough to patients.
Read the full article on TechCrunch